The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BIRKENSTOCK HOLDING PLC | COM SHS | M2029K104 | 43,460,300 | 1,010,000 | SH | DFND | 1 | 1,010,000 | 0 | 0 | |
| BLACKSTONE SECD LENDING FD | COMMON STOCK | 09261X102 | 23,729,395 | 1,000,818 | SH | DFND | 1 | 1,000,818 | 0 | 0 | |
| BLUE OWL CAPITAL CORPORATION | COM | 69121K104 | 13,046,652 | 1,200,244 | SH | DFND | 1 | 1,200,244 | 0 | 0 | |
| FIGMA INC | CLASS A COM STK | 316841105 | 240,416 | 13,290 | SH | DFND | 1 | 13,290 | 0 | 0 | |
| GOLDMAN SACHS BDC INC | SHS | 38147U107 | 20,783,876 | 2,192,392 | SH | DFND | 1 | 2,192,392 | 0 | 0 | |
| LINEAGE INC | COM | 53566V106 | 25,950,000 | 600,000 | SH | DFND | 1 | 600,000 | 0 | 0 | |
| MORGAN STANLEY DIRECT LENDIN | COM SHS | 61774A103 | 16,689,668 | 1,103,814 | SH | DFND | 1 | 1,103,814 | 0 | 0 | |
| NAVAN INC | CL A | 639193101 | 4,574,000 | 200,000 | SH | DFND | 1 | 200,000 | 0 | 0 | |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | 3,611,043 | 2,124,143 | SH | DFND | 1 | 2,124,143 | 0 | 0 | |
| SAILPOINT INC | COM | 78781J109 | 43,920,000 | 3,000,000 | SH | DFND | 1 | 3,000,000 | 0 | 0 | |